Latest Market News

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition after Cosette Pharmaceuticals changed its intentions to close the Salisbury manufacturing site, raising concerns over market transparency and regulatory approval.

Mount Hope Mining has withdrawn its recently announced Share Purchase Plan, citing challenging market conditions. Shareholders will receive full refunds within days.

Global X Management (AUS) Limited has announced estimated distribution amounts for three of its ETFs listed on the ASX AQUA Market for the period ending 30 November 2025, highlighting income opportunities for investors.

I Synergy Group’s subsidiary has inked four separate 12-month leases for its AI computing hardware and software, marking a strategic push into recurring revenue streams.

Astron Limited has received a pivotal Australian Taxation Office Class Ruling confirming capital gains tax roll-over relief for shareholders following its redomicile from Hong Kong to Australia. This development streamlines the company’s structure and offers potential long-term benefits to investors.

Tasmea Limited has announced the acquisition of WorkPac Group for up to A$60.7 million, significantly enhancing its workforce solutions capabilities and positioning the company for growth amid Australia's skilled labour shortages.

Tasmea Limited has entered a conditional agreement to acquire WorkPac Group for up to $60.7 million, aiming to enhance its workforce solutions and specialist trade services. The deal is expected to be accretive to earnings and strategically expand Tasmea’s footprint across Australia.

Tasmea Limited reported a stellar FY25 with strong revenue and profit growth, bolstered by strategic acquisitions and a robust dividend payout. The company signals continued momentum with a new acquisition announcement and targets ASX300 inclusion in 2026.

Garda Property Group has completed the $113.6 million sale of its North Lakes industrial site, sharply reducing debt and focusing its portfolio exclusively on Brisbane industrial assets. The group also secured a three-year extension on its debt facility with improved pricing, positioning itself for selective growth in private lending.

Altamin Limited has appointed GBA Capital as lead manager to place shortfall shares from its recent entitlement offer, offering broker options as part of the arrangement. This move aims to bolster support for its critical minerals projects in Italy while engaging new and existing investors.

Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.